UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial

The Lancet (British edition), 2014-05, Vol.383 (9929), p.1637-1647

2014

Volltextzugriff (PDF)

Hepatitis B Virus Surface Antigen Levels : A Guide to Sustained Response to peginterferon alfa-2a in HBeAg-Negative Chronic Hepatitis B

Hepatology (Baltimore, Md.), 2009-04, Vol.49 (4), p.1141-1150

2009

Volltextzugriff (PDF)

Controlled-Release Oxycodone vs. Placebo in the Treatment of Chronic Breathlessness—A Multisite Randomized Placebo Controlled Trial

Journal of pain and symptom management, 2020-03, Vol.59 (3), p.581-589

2020

Volltextzugriff (PDF)

Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial

Scientific reports, 2022-06, Vol.12 (1), p.10210-10210, Article 10210

2022

Volltextzugriff (PDF)

A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis

PloS one, 2020-05, Vol.15 (5), p.e0232394

2020

Volltextzugriff (PDF)

Living With Hereditary Angioedema in Australia: Findings From a National Observational Study Using Short Message Service to Monitor the Burden of Disease

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2023-08, Vol.11 (8), p.2457-2467.e1

2023

Volltextzugriff (PDF)

Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine

Human vaccines & immunotherapeutics, 2020-12, Vol.16 (12), p.3081-3089

2020

Volltextzugriff (PDF)

Gastric HER2 Testing Study (GaTHER): an evaluation of gastric/gastroesophageal junction cancer testing accuracy in Australia

The American journal of surgical pathology, 2012-04, Vol.36 (4), p.577-582

2012

Volltextzugriff (PDF)

A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis

European journal of obstetrics & gynecology and reproductive biology: X, 2021-04, Vol.10, p.100121-100121, Article 100121

2021

Volltextzugriff (PDF)

Using individual patient anatomy to predict protocol compliance for prostate intensity-modulated radiotherapy

Medical dosimetry : official journal of the American Association of Medical Dosimetrists, 2016, Vol.41 (1), p.70-74

2016

Volltextzugriff (PDF)

Estrogen and Progestin Compared with Simvastatin for Hypercholesterolemia in Postmenopausal Women

The New England journal of medicine, 1997-08, Vol.337 (9), p.595-601

1997

Volltextzugriff (PDF)

Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa‐2a in HBeAg‐negative chronic hepatitis B

Hepatology (Baltimore, Md.), 2009-04, Vol.49 (4), p.1141-1150

2009

Volltextzugriff (PDF)

Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

The New England journal of medicine, 2005-06, Vol.352 (26), p.2682-2695

2005

Volltextzugriff (PDF)

Combined Inhibin and CA125 Assays in the Detection of Ovarian Cancer

Clinical chemistry (Baltimore, Md.), 1999-05, Vol.45 (5), p.651-658

1999

Volltextzugriff (PDF)

A review of the treatment options for skin rash induced by EGFR-targeted therapies: Evidence from randomized clinical trials and a meta-analysis

Radiology and oncology, 2013-06, Vol.47 (2), p.166-175

2013

Volltextzugriff (PDF)

Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma

Journal of neuro-oncology, 2016-05, Vol.128 (1), p.67-74

2016

Volltextzugriff (PDF)

Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis

European journal of obstetrics & gynecology and reproductive biology, 2020-02, Vol.245, p.13-18

2020

Volltextzugriff (PDF)

A review of the treatment options for skin rash induced by EGFR-targeted therapies: Evidence from randomized clinical trials and a metaanalysis

Radiology and oncology, 2013-06, Vol.47 (2), p.166-175

2013

Volltextzugriff (PDF)

A simple algorithm to predict non‐compliance with organ at risk dose‐volume constraints when planning intensity modulated post‐prostatectomy radiation treatment: ‘Why we should put the CART before the horse’

Journal of medical imaging and radiation oncology, 2019-08, Vol.63 (4), p.546-551

2019

Volltextzugriff (PDF)

Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study

International journal of rheumatic diseases, 2017-04, Vol.20 (4), p.460-468

2017

Volltextzugriff (PDF)

Contemporary salvage post prostatectomy radiotherapy: Early implementation improves biochemical control

Journal of medical imaging and radiation oncology, 2018-04, Vol.62 (2), p.240-247

2018

Volltextzugriff (PDF)

Human epidermal growth factor receptor 2 status of breast cancer patients in Asia: Results from a large, multicountry study

Asia-Pacific journal of clinical oncology, 2016-12, Vol.12 (4), p.369-379

2016

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(52)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Life Sciences & Biomedicine
(34)
Humans
(26)
Female
(19)
Middle Aged
(15)
Adult
(13)
Male
(13)
Biological And Medical Sciences
(12)
General & Internal Medicine
(9)
Medicine, General & Internal
(9)
Aged
(8)
Medical Sciences
(8)
Clinical Trials
(7)
Treatment Outcome
(7)
Oncology
(6)
Patients
(6)
Clinical Medicine
(4)
Double-Blind Method
(4)
Estradiol - Blood
(4)
Fundamental And Applied Biological Sciences. Psychology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial

Hepatitis B Virus Surface Antigen Levels : A Guide to Sustained Response to peginterferon alfa-2a in HBeAg-Negative Chronic Hepatitis B

Controlled-Release Oxycodone vs. Placebo in the Treatment of Chronic Breathlessness—A Multisite Randomized Placebo Controlled Trial

Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial

A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis

Living With Hereditary Angioedema in Australia: Findings From a National Observational Study Using Short Message Service to Monitor the Burden of Disease

Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine

Gastric HER2 Testing Study (GaTHER): an evaluation of gastric/gastroesophageal junction cancer testing accuracy in Australia

A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis

Using individual patient anatomy to predict protocol compliance for prostate intensity-modulated radiotherapy

Estrogen and Progestin Compared with Simvastatin for Hypercholesterolemia in Postmenopausal Women

Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa‐2a in HBeAg‐negative chronic hepatitis B

Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

Blinatumomab in Combination with an Intensive Pediatric Protocol Results in High Rates of Day 79 MRD Negativity in Adolescent and Young Adult Acute Lymphoblastic Leukemia - Preliminary Results of the Australasian Leukaemia and Lymphoma Group (ALLG) ALL09 "Sublime” Study

Combined Inhibin and CA125 Assays in the Detection of Ovarian Cancer

A review of the treatment options for skin rash induced by EGFR-targeted therapies: Evidence from randomized clinical trials and a meta-analysis

Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma

Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis

A review of the treatment options for skin rash induced by EGFR-targeted therapies: Evidence from randomized clinical trials and a metaanalysis

A simple algorithm to predict non‐compliance with organ at risk dose‐volume constraints when planning intensity modulated post‐prostatectomy radiation treatment: ‘Why we should put the CART before the horse’

Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)

Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study

Contemporary salvage post prostatectomy radiotherapy: Early implementation improves biochemical control

A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocol

Human epidermal growth factor receptor 2 status of breast cancer patients in Asia: Results from a large, multicountry study

Suchergebnisse filtern